Metabolic syndrome: prevalence and risk factors in Korean gout patients
Jae Hyun Jung, Gwan Gyu Song, Jong Dae Ji, Young Ho Lee, Jae-Hoon Kim, Young Ho Seo, Sung Jae Choi
Korean J Intern Med. 2018;33(4):815-822. Published online 2016 Oct 12 DOI: https://doi.org/10.3904/kjim.2016.062
Citations to this article as recorded by 
Prevalence and treatment rate of gout by depressive symptom severity: A cross‐sectional analysis of NHANES 2007–2018
Siyi Lu, Tangliang Qian, Fengjiao Cao, Tianlun Kang, Xiaoping Liu, Chaoxin Wang, Yun Xia, Xiujuan Hou
International Journal of Rheumatic Diseases.2024;[Epub] CrossRef
Polymorphism rs3733591 of the SLC2A9 gene and metabolic syndrome affect gout risk in Taiwan Biobank subjects
Chun-Nan Lin, Chien-Chang Ho, Pao-Chun Hsieh, Chih-Hsuan Hsiao, Oswald Ndi Nfor, Yung-Po Liaw
Frontiers in Genetics.2024;[Epub] CrossRef
Managing Gout in Patients with Metabolic Syndrome
Esther Ebstein, Sébastien Ottaviani
Drugs & Aging.2024; 41(8): 653. CrossRef
Gout comorbidities: results from the Korean National Health and Nutrition Examination Survey
Hyemin Jeong, Young-Soo Chang, Chan Hong Jeon
Advances in Rheumatology.2024;[Epub] CrossRef
The associations of insulin resistance, obesity, and lifestyle with the risk of developing hyperuricaemia in adolescents
Linyan Cheng, Jinhu Zhou, Ying Zhao, Na Wang, Minya Jin, Wen Mao, Guangjun Zhu, Donglian Wang, Junbo Liang, Bo Shen, Yufen Zheng
BMC Endocrine Disorders.2024;[Epub] CrossRef
Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean
Joong Kyong Ahn
Journal of Rheumatic Diseases.2023; 30(2): 88. CrossRef
Altered Risk of Incident Gout According to Changes in Metabolic Syndrome Status: A Nationwide, Population‐Based Cohort Study of 1.29 Million Young Men
Yeonghee Eun, Kyungdo Han, Seung Woo Lee, Kyunga Kim, Seonyoung Kang, Seulkee Lee, Hoon‐Suk Cha, Eun‐Mi Koh, Hyungjin Kim, Jaejoon Lee
Arthritis & Rheumatology.2023; 75(5): 806. CrossRef
Culture and establishment of self-renewing human liver 3D organoids with high uric acid for screening antihyperuricemic functional compounds
Chuanli Hou, Wanqian Sha, Zhenzhen Xu, Yang Hu, William Kwame Amakye, Maojin Yao, Jiaoyan Ren
Food Chemistry.2022; 374: 131634. CrossRef
Association between Gout and Dyslipidemia: A Nested Case–Control Study Using a National Health Screening Cohort
Hyo Geun Choi, Bong-Cheol Kwon, Mi Jung Kwon, Ji Hee Kim, Joo-Hee Kim, Bumjung Park, Jung Woo Lee
Journal of Personalized Medicine.2022; 12(4): 605. CrossRef
Risk factors of urinary calculi in men with gout
Yu Cao, Xinxin Han, Xiaoxue Wang, Yun Zhang, He Xiao, Xuejun Zeng
Clinical Rheumatology.2022; 41(10): 3143. CrossRef
Increased risk of incident gout in young men with metabolic syndrome: A nationwide population-based cohort study of 3.5 million men
Yeonghee Eun, Kyungdo Han, Seung Woo Lee, Kyunga Kim, Seonyoung Kang, Seulkee Lee, Hoon-Suk Cha, Eun-Mi Koh, Hyungjin Kim, Jaejoon Lee
Frontiers in Medicine.2022;[Epub] CrossRef
The Risk of BPPV, Meniere’s Disease, and Vestibular Neuronitis in Patients with Gout: A Longitudinal Follow-Up Study Using a National Health Screening Cohort
Hyo Geun Choi, So Young Kim, Juyong Chung
Journal of Clinical Medicine.2022; 12(1): 185. CrossRef
A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank
Guiying Dong, Jianfeng Feng, Fengzhu Sun, Jingqi Chen, Xing-Ming Zhao
Genome Medicine.2021;[Epub] CrossRef
Simple metabolic markers associated with tophaceous gout
Wei Liu, Hui Song, Siliang Man, Hongchao Li, Siming Gao
Clinical Rheumatology.2021; 40(12): 5047. CrossRef
What is the Best Choice for Urate-lowering Therapy for Korean?
Yun-Hong Cheon, Jung Soo Song
Journal of Rheumatic Diseases.2020; 27(2): 78. CrossRef
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Mats Dehlin, Lennart Jacobsson, Edward Roddy
Nature Reviews Rheumatology.2020; 16(7): 380. CrossRef
Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on In Vitro Hepatic Lipogenesis-Related Gene Expression
Yi-Jen Fang, Tien-Yuan Wu, Cheng-Li Lin, Chih-Yang Su, Jia-Rong Li, Yun-Lung Chung, Ni Tien, Yun-Ping Lim, Agnieszka Dobrzyn
Mediators of Inflammation.2020; 2020: 1. CrossRef
Novel xanthine oxidase-based cell model using HK-2 cell for screening antihyperuricemic functional compounds
Chuanli Hou, Dan Liu, Ming Wang, Congcong Gong, Yujuan Li, Liu Yang, Maojin Yao, Erdong Yuan, Jiaoyan Ren
Free Radical Biology and Medicine.2019; 136: 135. CrossRef
Efficacy of uric acid‐lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients
Jing Wu, Yu‐Ping Zhang, Yuan Qu, Li‐Gang Jie, Jia‐Xin Deng, Qing‐Hong Yu
International Journal of Rheumatic Diseases.2019; 22(8): 1445. CrossRef
Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D
Alan Sacerdote, Paulomi Dave, Vladimir Lokshin, Gül Bahtiyar
Current Diabetes Reports.2019;[Epub] CrossRef
Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China
Yi Zhang, Yong Yang, Leixi Xue, Jian Wen, Lin Bo, Mei Tang, Ru Yang, Dong Yan, Zhichun Liu
BMJ Open.2019; 9(8): e025528. CrossRef
Decreased incidence of diabetes in patients with gout using benzbromarone
Sheng-Wen Niu, Kai-Ting Chang, Albert Ta, Yu-Han Chang, I Ching Kuo, Chi-Chih Hung, Yi-Wen Chiu, Shang-Jyh Hwang, Sheng-Fung Lin, Hugo You-Hsien Lin
Rheumatology.2018;[Epub] CrossRef
Prevalence and characteristics of metabolic syndrome in gout patients in a hospital setting in sub-Saharan Africa
Marie Doualla-Bija, Yonathan Lobe Batchama, Jude Moutchia-Suh, Vicky Joceline Ama Moor, Félicité Kamdem, Fernando Kemta Lekpa, Henry Luma Namme
Diabetes & Metabolic Syndrome: Clinical Research &.2018;[Epub] CrossRef
New Classification Criteria and Guideline for Management of Gout
Jung Soo Song
The Korean Journal of Medicine.2018; 93(4): 344. CrossRef